CIK 0001649904
- Large accelerated filer
RHYTHM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RYTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 462159271
- Phone
- +1 857-264-4280
- Business address
- 222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
- Former names
- RHYTHM METABOLIC, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,753,355
- in 2 filings, $11.8M under 10b5-1 plans
Net −$11,753,355. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-09 | Lee Jennifer Kayden EVP, Head of North America | Option exercise 10b5-1 | +3,438 | $6.80 | $23K | 5,085 |
| 2023-11-09 | Lee Jennifer Kayden EVP, Head of North America | Sale 10b5-1 | −1,719 | $27.37 | $47K | 3,366 |
| 2023-11-09 | Lee Jennifer Kayden EVP, Head of North America | Sale 10b5-1 | −1,719 | $28.00 | $48K | 1,647 |
| 2023-11-09 | Lee Jennifer Kayden EVP, Head of North America | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,438 | 58,442 | ||
| 2023-11-08 | Lee Jennifer Kayden EVP, Head of North America | Option exercise 10b5-1 | +5,712 | $6.80 | $39K | 7,359 |
| 2023-11-08 | Lee Jennifer Kayden EVP, Head of North America | Sale 10b5-1 | −3,479 | $28.64 | $100K | 3,880 |
| 2023-11-08 | Lee Jennifer Kayden EVP, Head of North America | Sale 10b5-1 | −2,233 | $29.31 | $65K | 1,647 |
| 2023-11-08 | Lee Jennifer Kayden EVP, Head of North America | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,712 | 61,880 | ||
| 2023-11-03 | Lee Jennifer Kayden EVP, Head of North America | Option exercise 10b5-1 | +80 | $6.80 | $544 | 1,727 |
| 2023-11-03 | Lee Jennifer Kayden EVP, Head of North America | Sale 10b5-1 | −80 | $28.00 | $2K | 1,647 |
| 2023-11-03 | Lee Jennifer Kayden EVP, Head of North America | Option exercise · Stock Option (Right to Buy) 10b5-1 | −80 | 67,592 | ||
| 2023-09-05 | Lee Jennifer Kayden EVP, Head of North America | Option exercise 10b5-1 | +4,519 | $6.80 | $31K | 7,813 |
| 2023-09-05 | Lee Jennifer Kayden EVP, Head of North America | Sale 10b5-1 | −6,166 | $28.05 | $173K | 1,647 |
| 2023-09-05 | Lee Jennifer Kayden EVP, Head of North America | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,519 | 67,672 | ||
| 2023-08-09 | Lee Jennifer Kayden EVP, Head of North America | Option exercise 10b5-1 | +1,718 | $6.80 | $12K | 5,012 |
| 2023-08-09 | Lee Jennifer Kayden EVP, Head of North America | Sale 10b5-1 | −1,718 | $24.66 | $42K | 3,294 |
| 2023-08-09 | Lee Jennifer Kayden EVP, Head of North America | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,718 | 72,191 | ||
| 2023-08-07 | Lee Jennifer Kayden EVP, Head of North America | Option exercise 10b5-1 | +8,591 | $6.80 | $58K | 14,517 |
| 2023-08-07 | Lee Jennifer Kayden EVP, Head of North America | Sale 10b5-1 | −11,223 | $24.18 | $271K | 3,294 |
| 2023-08-07 | Lee Jennifer Kayden EVP, Head of North America | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,591 | 73,909 |
Page 33 of 36 · 701 trades